Wegovy Cost in the UK (2026): NHS, Private, and Provider-by-Provider Pricing

TL;DR: Wegovy costs £9.90 per prescription on the NHS in England (free in Scotland, Wales, and Northern Ireland), but NHS access requires a specialist referral with average waits of 16 months. Privately, prices range from £75 to £299 per month depending on dose and provider. The cheapest providers (SheMed, Asda Online Doctor, Numan) undercut high-street pharmacies like Boots by 30% to 60%. At the 2.4mg maintenance dose, annual private costs run £1,900 to £3,600. Mounjaro is priced similarly at £130 to £340 per month. UK private health insurance (BUPA, AXA, Vitality) does not cover weight loss medication as a standard benefit, though Vitality offers member discounts of up to 20%.

Wegovy pricing in the UK has two distinct realities. Through the NHS, it's nearly free. Through a private prescription, it costs as much as a car payment. The difference comes down to eligibility, waiting times, and where you choose to buy.

With over 40 registered online pharmacies now selling Wegovy, prices vary more than most people realise. The same dose from the same manufacturer can cost £75 from one provider and £299 from another. This guide maps out every pricing tier, compares Wegovy against Mounjaro and Saxenda, and lays out concrete strategies for reducing costs.

For a full walkthrough of who can prescribe Wegovy, NHS eligibility criteria, and how the new 7.2mg dose works, see how to get Wegovy in the UK.

NHS Pricing: What You'll Pay (If You Qualify)

On the NHS, Wegovy is available through Tier 3 and Tier 4 specialist weight management services. Patient costs are minimal.

| UK Nation | Prescription Charge | |---|---| | England | £9.90 per prescription | | Scotland | Free | | Wales | Free | | Northern Ireland | Free |

In England, a Prescription Prepayment Certificate (PPC) can reduce costs further. A 12-month PPC costs £111.60 and covers unlimited NHS prescriptions. If you're collecting Wegovy monthly alongside other medications, this caps your total annual prescription costs regardless of how many scripts you fill.

What the NHS Pays

The manufacturer's list prices for Wegovy (before confidential NHS discount) are:

| Dose | List Price Per Pen (4 doses) | |---|---| | 0.25mg, 0.5mg, 1mg | £73.25 | | 1.7mg | £124.53 | | 2.4mg | £175.80 |

NICE confirmed that Novo Nordisk provides an additional confidential discount to the NHS. The actual cost to the health service is lower than these list prices, though the exact figure is commercially sensitive.

At maintenance dose (2.4mg), the NHS pays roughly £175 per month per patient at list price (likely less with the discount), while the patient pays £9.90 in England or nothing elsewhere. That's a subsidy of over 90%.

The Access Problem

The arithmetic above only applies if you can actually access NHS Wegovy. As detailed in the access guide, Tier 3 specialist weight management services have average waiting times of 16 months, with some areas exceeding two years. Only 76% of Integrated Care Boards commission Tier 3 services at all.

This means the effective cost for most people includes either the cost of waiting (16+ months without treatment) or the cost of starting privately while waiting for an NHS appointment. Some patients begin on a private prescription and transition to NHS once their specialist appointment comes through.

Private Pricing: The Full Breakdown

Private Wegovy prescriptions are available from dozens of GPhC-registered online pharmacies, high-street pharmacy chains, and private clinics. Pricing varies dramatically between providers, even for identical products.

Pricing by Dose (Range Across Providers)

| Dose | Titration Phase | Monthly Cost (Low) | Monthly Cost (Mid) | Monthly Cost (High) | |---|---|---|---|---| | 0.25mg | Weeks 1 to 4 | £75 | £89 to £99 | £169 to £199 | | 0.5mg | Weeks 5 to 8 | £75 | £109 to £119 | £179 to £199 | | 1mg | Weeks 9 to 12 | £125 to £139 | £139 to £149 | £189 to £199 | | 1.7mg | Weeks 13 to 16 | £149 to £159 | £169 to £179 | £229 to £249 | | 2.4mg | Maintenance | £159 to £189 | £189 to £199 | £249 to £299 |

The price difference between the cheapest and most expensive provider for the same 2.4mg dose can be £100+ per month, which compounds to over £1,200 per year in savings.

Provider Comparison: Who Charges What

Here's how some of the major UK providers price Wegovy at the 2.4mg maintenance dose (prices as of March 2026):

| Provider | 2.4mg Monthly Cost | Includes | |---|---|---| | SheMed | ~£159 | Consultation, prescription, delivery | | Asda Online Doctor | £189 to £199 | Consultation, prescription, delivery | | Numan | ~£143 | Programme access, nutritionist, delivery | | Juniper | ~£139 to £175 | Health coaching, app, delivery | | The Independent Pharmacy | ~£189 | Consultation, prescription, delivery | | Boots Online Doctor | ~£299 | Consultation, prescription, Boots dispensing | | Superdrug | ~£250 to £275 | Consultation, prescription, delivery |

Boots and Superdrug charge a significant premium over online-only providers. This reflects their high-street infrastructure costs and brand positioning, not a difference in the medication itself. All providers dispense the same Novo Nordisk product.

First-Year Cost Projection

Your first year on Wegovy involves four months of dose titration (starting at 0.25mg and increasing to 2.4mg) followed by eight months at the maintenance dose. Here's what that looks like at different price tiers:

| Price Tier | Months 1 to 4 (Titration) | Months 5 to 12 (Maintenance) | First-Year Total | |---|---|---|---| | Budget provider | ~£400 to £520 | ~£1,270 to £1,510 | ~£1,670 to £2,030 | | Mid-range provider | ~£500 to £640 | ~£1,510 to £1,590 | ~£2,010 to £2,230 | | Premium provider | ~£760 to £850 | ~£2,000 to £2,390 | ~£2,760 to £3,240 |

These projections assume no consultation fees beyond what's bundled into the monthly price. Some providers charge a separate initial consultation fee (£20 to £150).

How Wegovy Compares to Alternatives

Mounjaro (Tirzepatide)

Mounjaro is the main competitor to Wegovy in the UK market. It's MHRA-approved for weight management and NICE-recommended through the same Tier 3 specialist pathway.

| Dose | Monthly Cost (Low) | Monthly Cost (High) | |---|---|---| | 2.5mg (starter) | £130 | £220 | | 5mg | £140 | £240 | | 7.5mg | £170 | £260 | | 10mg | £190 | £290 | | 15mg (maximum) | £210 | £340 |

At maintenance doses, Mounjaro and Wegovy cost roughly the same from budget providers (£159 to £210 per month). The clinical differences matter: Mounjaro targets two receptors (GIP and GLP-1) and clinical trials showed approximately 20.9% average body weight loss at the 15mg dose, compared to 15% to 17% for Wegovy at 2.4mg. The new Wegovy 7.2mg dose (approved in the UK January 2026) narrows that gap, with trial data showing 18.7% to 20.7% weight loss.

One pricing note: Eli Lilly increased Mounjaro's wholesale price significantly in September 2025. Some providers absorbed the increase; others passed it through. This created wider price variation between providers than existed previously.

For a detailed comparison of semaglutide and tirzepatide, see the four main GLP-1 drugs explained.

Saxenda (Liraglutide)

Saxenda is a daily GLP-1 injection (versus weekly for Wegovy and Mounjaro). It produces more modest weight loss (5% to 10% average versus 15% to 20%+) and requires self-injection every day.

Private cost: £150 to £300 per month, with most patients paying £200 to £275 at maintenance dose.

Saxenda made more sense when it was the only approved option. With Wegovy and Mounjaro available at similar or lower monthly costs and better efficacy, Saxenda is now primarily relevant for patients who've tried and can't tolerate semaglutide or tirzepatide.

Orlistat

The cheapest weight loss medication available in the UK. Orlistat (branded as Xenical on prescription, Alli over the counter) costs approximately £15 to £30 per month. It blocks fat absorption rather than suppressing appetite. Average weight loss is 3% to 5% beyond diet and exercise, significantly less than GLP-1 drugs.

Available on the NHS from your GP without a specialist referral, making it the most accessible option for people who don't meet GLP-1 eligibility criteria or can't afford private pricing.

Side-by-Side Annual Cost

| Medication | Monthly Cost (Maintenance) | Annual Cost | Avg Weight Loss | Frequency | |---|---|---|---|---| | Wegovy 2.4mg | £159 to £299 | £1,900 to £3,600 | 15% to 17% | Weekly injection | | Wegovy 7.2mg | Pricing stabilising | TBC | 18.7% to 20.7% | Weekly (3 injections) | | Mounjaro 15mg | £210 to £340 | £2,520 to £4,080 | ~20.9% | Weekly injection | | Saxenda | £200 to £275 | £2,400 to £3,300 | 5% to 10% | Daily injection | | Orlistat | £15 to £30 | £180 to £360 | 3% to 5% | Oral, with meals |

Weight loss percentages are approximate averages from clinical trials with lifestyle interventions.

Private Health Insurance: Coverage Reality

UK private medical insurance (PMI) is designed for acute conditions, and weight management medication falls outside that model. The practical result: standard policies from BUPA, AXA Health, and Vitality do not cover Wegovy or Mounjaro prescriptions.

What Each Insurer Offers

Vitality: Became the first major UK insurer to offer member discounts (up to 20%) on GLP-1 weight loss medicines in 2025. This is a discount, not insurance coverage: you still pay for the medication, just at a reduced price through Vitality's partner pharmacies.

BUPA: Offers a Weight Management Plan as a paid add-on (separate from standard PMI). This provides access to Wegovy on a pay-as-you-go basis through BUPA's clinical pathway, but the medication cost itself isn't covered by insurance.

AXA Health: Explicitly excludes outpatient prescriptions from its standard policies, which rules out any weight loss medication coverage.

Most employer schemes: Follow the same exclusion pattern as individual PMI. A small number of larger employers have begun including weight management medication as a standalone wellness benefit, but this is uncommon and typically offered as a fixed subsidy rather than full coverage.

The Bottom Line on Insurance

If you have UK private health insurance, assume it will not cover Wegovy. Budget for the full private cost.

How to Spend Less

1. Compare Providers at Your Maintenance Dose

Starter dose pricing is competitive across providers because it's the price everyone sees first. The meaningful comparison is at 2.4mg (the dose you'll be on for months or years). A £100 monthly saving at maintenance dose is worth £1,200 per year.

2. Check What's Included

Some providers bundle consultations, blood tests, and ongoing clinical support into their monthly price. Others charge these separately. A headline price of £159 that includes everything may be cheaper than a £139 price plus £50 quarterly consultations plus £30 annual blood work.

3. Start the NHS Referral Now

Even if you plan to start privately, ask your GP for a referral to Tier 3 specialist weight management services immediately. The 16-month average wait means your appointment may come through while you're still in your first year of treatment. Transitioning from private to NHS at that point could save £2,000+ annually.

4. Use a Prescription Prepayment Certificate (If on NHS)

If you're fortunate enough to get NHS access in England, a 12-month PPC at £111.60 covers unlimited prescriptions. That's £111.60 per year versus £118.80 (12 monthly prescriptions at £9.90 each). Small savings, but it extends to all your prescriptions, not just Wegovy.

5. Consider Mounjaro as a Price Competitor

In some cases, Mounjaro's pricing undercuts Wegovy at equivalent stages. This is particularly true at the starter dose level, where Mounjaro 2.5mg can be found for £130 versus Wegovy 0.25mg at £75 to £169. At maintenance doses, pricing converges. If your prescriber recommends either as clinically appropriate, price can be a valid deciding factor.

What's Changing

Generic Semaglutide (Internationally)

Semaglutide patents have already expired in India and Canada. In India, 40+ generic manufacturers launched within a week of patent expiry at prices 70% to 90% lower than branded Wegovy. In Canada, nine manufacturers are in the Health Canada review pipeline, with generics expected by Q3 2026. See generic semaglutide in India and generic semaglutide in Canada for details.

UK semaglutide patents extend further, so domestic generics aren't imminent. International generic availability may eventually put downward pressure on UK pricing, though how and when is uncertain.

Oral Semaglutide

A pill form of semaglutide for weight management is in late-stage development. If MHRA-approved, it would remove the injection barrier and could alter the competitive landscape, particularly if oral formulations are priced differently than injectables.

Expanded NHS Capacity

NHS England's 2025 to 2026 enhanced weight management service specification signals intent to increase Tier 2 and Tier 3 capacity. If waiting lists shorten, more patients could access NHS-funded medication at £9.90 per prescription rather than paying full private prices.

Cost vs Value: The Longer View

At £159 to £299 per month (roughly £1,900 to £3,600 per year), private Wegovy is a significant financial commitment. For context, that's comparable to a mid-range gym membership combined with a meal prep service.

Clinical trial data shows average weight loss of 15% to 17% of body weight at the 2.4mg dose, sustained over 68 weeks of treatment. For someone weighing 100kg, that's 15 to 17kg. NICE determined that semaglutide is cost-effective for the NHS, accounting for reductions in cardiovascular events, type 2 diabetes incidence, and other obesity-related health costs.

The evidence also shows that most people regain weight after stopping GLP-1 medication unless they've made lasting changes to eating patterns and activity levels. The medication works best as part of a broader approach. For the psychological and behavioural dimensions of that equation, why diets fail at the psychological level offers an evidence-based perspective on what makes the difference between temporary and lasting change.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any medication, including semaglutide. Pricing is approximate, varies by provider, and is subject to change. For the latest NICE guidance, visit nice.org.uk.

Ready to stop fighting your cravings and start reprogramming your mind for lasting success? The Hypna AI 21-day self-hypnosis program is designed to help you rewire subconscious patterns and build a healthier relationship with food from the inside out.